Drug Testing in Anesthesia: "Prevention and Protection" or "Major Risk for Minimal Gain"

Anesth Analg. 2021 Mar 1;132(3):916-919. doi: 10.1213/ANE.0000000000005350.

Authors

Michael G Fitzsimons¹, Mark J Rice², Keith Baker³

Affiliations

¹ From the Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts.
² Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.
³ Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

PMID: 33438964
DOI: 10.1213/ANE.0000000000005350

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anesthesiologists* / economics
Cost-Benefit Analysis
Humans
Mandatory Testing* / economics
Medical Errors / economics
Medical Errors / prevention & control*
Patient Safety
Physician Impairment* / economics
Program Development
Program Evaluation
Recreational Drug Use
Reproducibility of Results
Substance Abuse Detection* / economics
Substance-Related Disorders / diagnosis
Substance-Related Disorders / economics
Substance-Related Disorders / prevention & control*